Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2066]

Pursuing the 'elusive' proton CT

Prof Nigel Allinson - University of Lincoln, Lincoln, UK

Pursuing the 'elusive' proton CT ( Prof Nigel Allinson - University of Lincoln, Lincoln, UK )

Proton accelerators for cancer therapy

Dr Stephen Myers - AVO, Geneva, Switzerland

Proton accelerators for cancer therapy ( Dr Stephen Myers - AVO, Geneva, Switzerland )

When is an assay ready for the clinic?

Dr Erasmus Schneider - Wadsworth Center, Albany, USA

When is an assay ready for the clinic? ( Dr Erasmus Schneider - Wadsworth Center, Albany, USA )

Building a succesful proton therapy centre

Prof James Metz - University of Pennsylvania, Philadelphia, USA

Building a succesful proton therapy centre ( Prof James Metz - University of Pennsylvania, Philadelphia, USA )

Practical implementation of proton therapy in the UK

Prof Karol Sikora - Proton Partners International, Cardiff, UK

Practical implementation of proton therapy in the UK ( Prof Karol Sikora - Proton Partners International, Cardiff, UK )

The use of proton therapy in relatively new indications

Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic

The use of proton therapy in relatively new indications ( Dr Jiří Kubeš - Proton Therapy Center Czech, Prague, Czech Republic )

Proton therapy for paediatric indications

Prof Roger Taylor - Swansea University Medical School, Swansea, UK

Proton therapy for paediatric indications ( Prof Roger Taylor - Swansea University Medical School, Swansea, UK )

A model-based selection approach to identify suitable indications for proton...

Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands

A model-based selection approach to identify suitable indications for proton therapy ( Prof Johannes Langendijk - University of Groningen, Groningen, Netherlands )

IBCD 2016: Patient access and regulatory challenges

Dr Denis Lacombe - EORTC Director General

IBCD 2016: Patient access and regulatory challenges ( Dr Denis Lacombe - EORTC Director General )

Taking complex genomic analysis into practice

Dr Philip Beer - Sanger Institute, Hinxton, UK

Taking complex genomic analysis into practice ( Dr Philip Beer - Sanger Institute, Hinxton, UK )

Genomic characterisation and risk stratification of AML

Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK

Genomic characterisation and risk stratification of AML ( Dr Moritz Gerstung - European Bioinformatics Institute, Hinxton, UK )

Screening Patients for Efficient Clinical Trial Access (SPECTA)

Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium

Screening Patients for Efficient Clinical Trial Access (SPECTA) ( Dr Vassilis Golfinopoulos - EORTC, Brussels, Belgium )

More from ecancer